Concise review: Ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: Basic principles, experimental approaches, and impact in regenerative medicine

Stem Cells Translational Medicine

Volumn 2, Issue 11, 2013, Pages 830-838

  Flores Guzmán, Patricia ^a   Fernández Sánchez, Verónica ^a   Mayani, Hector ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Hematopoietic progenitors; Hematopoietic stem cells; Stem cell expansion; Umbilical cord blood

Indexed keywords

ALPHA6 INTEGRIN; CD133 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NOTCH RECEPTOR; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; UMBILICAL CORD BLOOD;

EID: 84886536849     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0071     Document Type: Article

References (111)

1. Mayani H. Umbilical cord blood: Lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res 2011;42:645-651.
2. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-4678.
3. Mayani H, Lansdorp PM. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. STEM CELLS 1998;16:153-165.
4. Knudtzon S. In vitro growth of granulocyte colonies from circulating cells in human cord blood. Blood 1974;43:357-361.
5. Leary AG, Ogawa M. Blast cell colony assay from umbilical cord blood and adult bone marrow progenitors. Blood 1987;69:953-956.
6. Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/ progenitor cells. Proc Natl Acad Sci USA 1989; 86:3828-3832.
7. Mayani H. Biological differences between neonatal and adult human hematopoietic stem/progenitor cells. Stem Cells Dev 2010;19: 285-298.
8. Abboud M, Xu F, LaVia M et al. Study of early hematopoietic precursors in human cord blood. Exp Hematol 1992;20:1043-1047.
9. Traycoff CM, Abboud MR, Laver J et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994;22:215-222.
10. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992;89:4109-4113.
11. Hows JM, Bradley BA, Marsh JCW et al. Growth of human umbilical cord blood in longterm haemopoietic cultures. Lancet 1992; 340:73-76.
12. Steen R, Tjonnfjord GE, Egeland T. Comparison of the phenotype and clonogenicity of normal CD34 cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother 1994;3:253-262.
13. Mayani H, Gutiérrez-Rodríguez M, Espinoza L et al. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells. STEM CELLS 1998;16:127-135.
14. Pettengell R, Luft T, Henschler R et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood and blood stem cells. Blood 1994;84:3653-3659.
15. Wang JCY, Doedens JCY, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89:3919-3924.
16. Gluckman E, Rocha V, Arcese W et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004;32:397-407.
17. Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-2722.
18. Christopherson KW, Hangoc G, Mantel CR et al. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004;305:1000-1003.
19. Farag SS, Broxmeyer HE. CD26 inhibition to enhance cord blood engraftment. In: Broxmeyer HE, ed. Cord Blood: Biology, Transplantation, Banking, and Regulation. Bethesda, MD: AABB Press, 2011:203-213.
20. Frassoni F, Podesta M, Varaldo R et al. Intrabone transplantation of cord blood cells and the journey of hematopoietic cells. In: Broxmeyer HE, ed. Cord Blood: Biology, Transplantation, Banking, and Regulation. Bethesda, MD: AABB Press, 2011:239-252.
21. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007;137:20-35.
22. Haspel RL, Ballen KK. Double cord blood transplants: Filling a niche? Stem Cell Rev 2006; 2:81-86.
23. Gutman JA, Turtle CJ, Manley TJ et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8 T cell response against the nonengrafted unit. Blood 2010;115:757-765.
24. Avery S, Shi W, Lubin M et al. Influence of infused cell dose and HLA on engraftment after double-unit cord blood allografts. Blood 2011; 117:3277-3285.
25. Kelly SS, Parmar S, De Lima M et al. Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy 2010;12:121-130.
26. Dahlberg A, Delaney C, Bernstein I. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 2011;117:6083-6090.
27. Szilvassy SJ. The biology of hematopoietic stem cells. Arch Med Res 2003;34:446-460.
28. Wognum AW, Eaves AC, Thomas TE. Identification and isolation of hematopoietic stem cells. Arch Med Res 2003;34:461-475.
29. Notta F, Doulatov S, Laurenti E et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011;333:218-221.
30. Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immunodeficient mice. Proc Natl Acad Sci USA 1997;94:5320-5325.
31. null) NOD-SCID mice are excellent recipients for studying human hematopoietic stem cell function. Blood 2000;95: 3102-3105.
32. Coutinho LH, Gilleece MH, De Wynter EA et al. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G, eds. Haemopoiesis: A Practical Approach. Oxford, U.K.: Oxford University Press, 1993:75-106.
33. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992;49:225-233.
34. Scadden DT. The stem cell niche as an entity of action. Nature 2006;441:1075-1079.
35. Morrison SJ, Spradling AC. Stem cells and niches: Mechanisms that promote stem cell maintenance throughout life. Cell 2008;132: 598-611.
36. Nagasawa T, Omatsu Y, Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: The role of reticular cells. Trends Immunol 2011;32:315-320.
37. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013;495:231-235.
38. Douay L. Experimental culture conditions are critical for the ex-vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 2001;10:341-346.
39. McNiece I, Harrington J, Turney J et al. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 2004;6:311-317.
40. Robinson SN, Ng J, Niu T et al. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant 2006;37:359-366.
41. Madkaikar M, Ghosh K, Gupta M et al. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol 2007;118: 153-159.
42. Andrade PZ, Lobato da Silva C, dos Santos F et al. Initial CD34 cell-enrichment determines hematopoietic stem/progenitor cell yield upon ex vivo expansion. J Cell Biochem 2011;112:1822-1831.
43. Flores-Guzman P, Fernandez-Sanchez V, Valencia-Plata I et al. Comparative in vitro analysis of different hematopoietic cell populations from human cord blood: In search of the best option for clinically-oriented ex vivo cell expansion. Transfusion 2013;53:668-678.
44. low progenitor cells from human umbilical cord blood. Exp Hematol 1994;22:1244-1251.
45. Cardoso A, Li ML, Batard P. Release from quiescence of CD34 CD38 human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993;90: 8707-8711.
46. de Wynter EA, Nadali G, Coutinho L et al. Extensive amplification of single cells from CD34 subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets. STEM CELLS 1996;14:566-576.
47. Mayani H, Dragowska W, Lansdorp PM. Characterization of functionally distinct subpopulations of CD34 cord blood cells in serum-free long-term cultures supplemented with hematopoietic cytokines. Blood 1993;82: 2664-2672.
48. Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83: 2410-2417.
49. Mayani H, Lansdorp PM. Proliferation of individual hematopoietic progenitors purified from umbilical cord blood. Exp Hematol 1995; 23:1453-1462.
50. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
51. Gilmore GL, DePasquale DK, Lister J et al. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34 hematopoietic stem cells. Exp Hematol 2000;28:1297-1305.
52. Tanavde VM, Malehorn MT, Lumkul R et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002;30:816-823.
53. Mayani H, Dragowska W, Lansdorp PM. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood 1993;81:3252-3258.
54. Flores-Guzmán P, Gutiérrez-Rodríguez M, Mayani H. In vitro proliferation, expansion and differentiation of a CD34 cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res 2002;33:107-114.
55. Metcalf D. Hematopoietic cytokines. Blood 2008;111:485-491.
56. Ogawa M. Hemopoietic stem cells: Stochastic differentiation and humoral control of proliferation. Environ Health Perspect 1989; 80:199-207.
57. Dazzi F, Ramasamy R, Glennie S et al. The role of mesenchymal stem cells in haematopoiesis. Blood Rev 2006;20:161-171.
58. Kirouac DC, Madlambayan GJ, Yu M et al. Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol 2009;5:293.
59. Peerani R, Zandstra PW. Enabling stem cell therapies through stem cell-niche engineering. J Clin Invest 2010;120:60-70.
60. Rosler E, Brandt J, Chute J et al. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34 CD38 cells. Exp Hematol 2000;28:841-852.
61. Fei XM, Wu YJ, Chang Z et al. Co-culture of cord blood CD34 cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/ SCID mice. Cytotherapy 2007;9:338-347.
62. Hutton JF, Rosenkov V, Khor FSL et al. Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system. Stem Cells Dev 2006;15:805-813.
63. Ando K, Nakamura Y, Chargui J et al. Extensive generation of human cord blood CD34 stem cells from Lin CD34 cells in a long-term in vitro system. Exp Hematol 2000; 28:690-699.
64. Wang J-F, Wang L-J, Wu Y-F et al. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34 hematopoietic stem cells and for chondrogenic differentiation. Haematologica 2004;89:837-844.
65. Xie C-G, Wang J-F, Xiang Y et al. Cocultivation of umbilical cord blood CD34 cells with retro-transduced hMSC leads to effective amplification of long-term culture initiating cells. World J Gastroenterol 2006;12:393-402.
66. Wagner W, Roderburg C, Wein F et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. STEM CELLS 2007;25:2638-2647.
67. Jang YK, Jung DH, Jung MH et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006;85:212-225.
68. Flores-Guzmán P, Flores-Figueroa E, Montesinos JJ et al. Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood. Cytotherapy 2009;11:886-896.
69. Flores-Figueroa E, Montesinos JJ, Flores-Guzmán P et al. Functional analysis of myelo-dysplastic syndromes-derived mesenchymal stem cells. Leuk Res 2008;32:1407-1416.
70. Lewis ID, Almeida-Porada G, Du J et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001;97:3441-3449.
71. Fernández-Sánchez V, Pelayo R, Flores-Guzman P et al. In vitro effects of stromal cells expressing different levels of Jagged-1 and Delta-1 on the growth of primitive and intermediate CD34 cell subsets from human cord blood. Blood Cells Mol Dis 2011;47:205-213.
72. Lai EC. Notch signaling: Control of cell communication and cell fate. Development 2004;131:965-973.
73. Ohishi K, Katayama N, Shiku H et al. Notch signaling in hematopoiesis. Semin Cell Dev Biol 2003;14:143-150.
74. Duncan AW, Rattis FM, DiMascio LM et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005;6:314-322.
75. Delaney C, Heimfeld S, Brashem-Stein C et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010;16: 232-236.
76. Peled T, Landau E, Prus E et al. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood derived CD34 cells. Br J Haematol 2002;116:655-661.
77. Peled T, Mandel J, Goudsmid RN et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 2004;6:344-355.
78. Madlambayan GJ, Rogers I, Kirouac DC et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol 2005;33:1229-1239.
79. Madlambayan GJ, Rogers I, Purpura KA et al. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant 2006;12:1020-1030.
80. Csaszar E, Kirouac DC, Yu M et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 2012;10:218-229.
81. Flores-Guzmán P, Martinez-Jaramillo G, Montesinos JJ et al. Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells. Cytotherapy 2006;8:299-307.
82. Rogers IM, Yamanaka N, Casper RF. A simplified procedure for hematopoietic stem cell amplification using a serum-free, feeder cell-free culture system. Biol Blood Marrow Transplant 2008;14:927-937.
83. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood cells. Biol Blood Marrow Transplant 2002;8:368-376.
84. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: Results of a phase I trial using the AastromReplicell System. Blood 2003;101:5061-5067.
85. de Lima M, McMannis J, Gee A et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tertraethylenepentamine: A phase I/II clinical trial. Bone Marrow Transplant 2008;41:771-778.
86. de Lima M, McNiece I, McMannis J et al. Double cord blood transplantations (CBT) with ex vivo expansion (EXP) of one unit utilizing a mesenchymal stromal cell (MSC) platform. Biol Blood Marrow Transplant 2009;15:Supplement Abstract 122.
87. Mayani H. Notch signaling: From stem cell expansion to improving cord blood transplantation. Expert Rev Hematol 2010;3:401-404.
88. de Lima M, McNiece I, Robinson SN et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. New Engl J Med 2012; 367:2305-2315.
89. Verfaillie CM. Adult stem cells: Assessing the case for pluripotency. Trends Cell Biol 2002;12:502-508.
90. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. STEM CELLS 2004;22:487-500.
91. Vieyra DS, Jackson KA, Goodell MA. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev 2005;1: 65-70.
92. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
93. Theise ND, Nimmakayalu M, Gardner R et al. Liver from bone marrow in humans. Hepatology 2000;32:11-16.
94. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229-1234.
95. Brazelton TR, Rossi FMV, Keshet GI et al. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000;290: 1775-1779.
96. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-1782.
97. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
98. Ogawa M, LaRue AC, Watson PM et al. Hematopoietic stem cell origin of connective tissues. Exp Hematol 2010;38:540-547.
99. Singh AK, Kashyap MP, Jahan S et al. Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34 stem cell-derived differentiating neuronal cells. Toxicol Sci 2012;129:392-410.
100. Giorgetti A, Marchetto MC, Li M et al. Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. Proc Natl Acad Sci USA 2012;109:12556-12561.
101. Giorgetti A, Montserrat N, Aasen T et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009;5:353-357.
102. Zhao Y, Wang H, Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 2006;312:2454-2464.
103. Rogers I, Yamanaka N, Bielecki R et al. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp Cell Res 2007;313:1839-1852.
104. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995;1:1017-1023.
105. Bernstein ID, Delaney C. Engineering stem cell expansion. Cell Stem Cell 2012;10: 113-114.
106. Deutsch V, Hubel E, Kay S et al. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte progenitor cells from cord blood. Br J Haematol 2010;149:137-149.
107. Celebi B, Mantovani D, Pineault N. Effects of extracellular matrix proteins on the growth of haematopoietic progenitor cells. Biomed Mater 2011;6:055011.
108. Bhardwaj G, Murdoch B, Wu D et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001;2:172-178.
109. Watts KL, Delaney C, Humpries RK et al. Combination of HOXB4 and delta-1 ligand improves expansion of cord blood cells. Blood 2010;116:5859-5866.
110. Aguila JR, Liao W, Yang J et al. SALL4 is a robust stimulator for the expansion of hematopoietic stem cells. Blood 2011;118:576-585.
111. Ogawa M, LaRue AC, Mehrotra M. Hematopoietic stem cells are pluripotent and not just "hematopoietic." Blood Cells Mol Dis 2013;51:3-8.